An Open Label, Single Dose, Randomized, Two Way Crossover Study to Estimate Oxycodone Relative Bioavailability in Healthy Volunteers Following Administration of PF 00345439 Formulation K 40 Mg Under Fasting Conditions With 40% Ethanol Compared With Water
Phase of Trial: Phase I
Latest Information Update: 06 Apr 2016
At a glance
- Drugs Oxycodone (Primary) ; Naltrexone
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Pfizer
- 08 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 04 Aug 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 21 Jun 2014 New trial record